Altimmune appoints former gsk executive catherine angell sohn, pharm.d. to its board of directors

Gaithersburg, md., march 27, 2023 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced the appointment of catherine angell sohn, pharm.d. to its board of directors.

ALT Ratings Summary

ALT Quant Ranking